Publications

In this edition: Corticosteroids reduce risk of death among critically ill COVID-19 patients; Digital contact tracing technologies in pandemics; Relaunching our COVID-19 section

In this edition: BAME and COVID-19 rapid review; Co-production when we can’t meet face-to-face; The impact of social distancing on children

A PolicyBristol briefing report bringing together evidence from a range of research projects investigating strategies to reduce Hepatitis C transmission among people who inject drugs.

In this edition: Responding to the COVID-19 challenge with rapid research; New data research partnership will support the COVID-19 effort, plus much more.

The Hepatitis C Assessment to Treatment Trial (HepCATT) assessed whether a multipart intervention in 22 GP practices could increase testing, diagnosis and treatment of HCV-infected patients compared to usual care in 23 control practices, over one year.

A map of resources to guide researchers, professionals and public contributors through the different tools and guidance that can help people produce research together – this includes tools to support remote co-production, on p.13-18.

Reflective questions to help everyone think about how they can work with people more equally through a process of co-produced research, including online and remote co-production.

The email newsletter from ARC West. In this edition: Alcohol in pregnancy: #Drymester safest approach; Telling physical activity stories; Peer support groups for chronic pain; Plus much more

Worldwide, the number of children with higher weight is increasing. This can lead to health problems, as well as potentially affecting the children psychologically and socially. Preventing childhood obesity is an international public health priority.

Up to 4,000 papers are published every year on preventing childhood obesity. The Cochrane review on preventing childhood obesity had been last updated in 2011. We worked with Durham University, Fuse (the Centre for Translational Research in Public Health) and the World Health Organisation to update the Cochrane review with a synthesis of studies up to 2015.

Millions of inflammatory marker tests are ordered by GPs in England each year and rates of testing are rising. Many of these tests will be done appropriately, but GPs are increasingly using them as a non-specific test to rule out serious underlying disease. Until now there has been no evidence about whether this is a good strategy.